Navigation Links
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Date:2/14/2008

he c-Met, Tie-2, Ron and VEGF receptor tyrosine kinases. In addition, MethylGene's preclinical programs include: MGCD290 an HDAC inhibitor in combination with azoles for fungal infections and a sirtuins program for cancer. MethylGene's development and commercialization partners include Pharmion Corporation, Taiho Pharmaceutical and EnVivo Pharmaceuticals. Please visit our website at http://www.methylgene.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements relating to MGCD0103, which express the current beliefs and expectations of management. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause Pharmion's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to, the potential failure of MGCD0103, to demonstrate safety and efficacy in clinical and non-clinical testing; the ability to complete regulatory submissions and gain regulatory approvals in a timely manner; the ability to initiate and complete trials at the referenced times; the impact of competition from other products under development by Pharmion's competitors; the uncertainty of the regulatory environment and changes in the health policies of various countries; acceptance and demand for new pharmaceutical products and new therapies; uncertainties regarding market acceptance of products newly launched, currently being sold or in development; failure of third-party manufacturers to produce the product volumes required on a timely basis and fluctuations in currency exchange rates. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
4. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
5. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
6. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
7. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
8. Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
9. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
10. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
11. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... --A Harvard medical expert internationally recognized as a ... Tour,s decision last month to suspend Doug Barron ... as having the medical condition hypogonadism ... "unreasonable, unfair and discriminatory." ,, Hypogonadism ... levels, often referred to informally as Low ...
(Date:12/15/2009)... 15 Fenwal Inc., a global medical ... safety and availability, announced today that the U.S. ... to market InterSol ® platelet additive solution. ... is a specialized product used in combination with ... blood component used to prevent or treat bleeding. ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, Boehringer Ingelheim GmbH: ... ,, Introduction ,, This analysis ... Boehringer Ingelheim in the Rx pharmaceutical sector. ... pipeline analysis and assessment of financial performance, ...
Breaking Medicine Technology:Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Marine biomedicine researchers decode structure of promising sea compound 9730 1Marine biomedicine researchers decode structure of promising sea compound 9730 2Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 1Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 2Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 3Scans Shed New Light on Concussions 55629 1Scans Shed New Light on Concussions 55629 2
... and Reported Today ... Study Completed, HAMBURG, Germany and OXFORD, England, March ... to announce the,preliminary findings of a double-blind, single-dose, 3-way ... receptor antagonist, EVT,101. The study was performed in 19 ...
... In the medical,community at large, there is no ... in the heart muscle. Multiple attempts by medical,research scientists ... repair,itself after an individual suffers a heart attack have ... Critical Care Medicine, located in Rancho Mirage,California, is home ...
Other Medicine Technology:Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 2Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 3Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2
(Date:12/15/2009)... The U.S. Senate today rejected an amendment ... that would have helped make prescription drugs more ... importation of lower priced drugs from abroad. The ... Senators Dorgan, Snowe, McCain, Grassley and Stabenow, would ... the skyrocketing costs of prescription drugs. ,, The ...
(Date:12/15/2009)... NAPA, Calif., Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences ... healthy aging, today announced that shareholders had approved all three resolutions that the Company had ... were as follows: , , Description of ... Votes ... For ...
(Date:12/15/2009)... SUNNYVALE, Calif., Dec. 15 Palo Alto ... Shinshu University has deployed its PA-4000 Series next-generation ... network and for enhanced visibility and control over ... University is a Japanese national university with eight ... in 1949 by integrating a number of academic ...
(Date:12/15/2009)... to the Lupus Foundation of America and the Saint ... Julian Lennon, son of the legendary John ... digital single, "LUCY," to raise funds for research on ... 100 percent of the proceeds from downloading "LUCY" at ... America (LFA), and the Saint Thomas, Lupus Trust in ...
(Date:12/15/2009)... 15 Vitech Systems Group, a leading ... (CRM) software, announced today that it has completed ... the Screen Actors Guild-Producers Pension & Health Plans ... service capabilities to SAG-PH call center personnel in ... installed using Vitech,s V3 Benefits Administration System which ...
Breaking Medicine News(10 mins):Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2
... suffering a severe personality disorder are posing a big ... their best foot forward to find an answer to ... Act has indicated that chronically ill patients are advised ... poses a potential risk, both to themselves and to ...
... One in seven women will develop breast cancer in her ... this disease? // ,Breast cancer specialists from the University ... women more anxiety than necessary. And in some cases the ... that could lead to successful treatment. ,Here, experts ...
... that kids attending Montessori schools have an advantage over ... development. However, an early education researcher finds the study ... ,In this study, thirty 5-year old kids and twenty ... school in Milwaukee, Wis. were included. Equal numbers of ...
... that laws, which require minors to seek parental consent ... in this segment of the society. Jonathan Klick, the ... professor of economics at George Mason University examined the ... parental consent may play an important role. ...
... after researchers warned that some of them might ... ,The new data, culled from 140,000 patients, suggested ... risk. ,The European Medicines Agency which ... indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, nimesulide and ...
... step up health tourism investment along the lines of Kerala, ... // ,"Being a source of rare Himalayan herbs ... Lahe-Thapa, the Nepal Tourism Board's director of marketing and promotion, ... (in southern India), Thailand and Malaysia, we will be looking ...
Other Medicine News:Health News:16 Common Myths About Breast Cancer 2Health News:16 Common Myths About Breast Cancer 3Health News:16 Common Myths About Breast Cancer 4Health News:16 Common Myths About Breast Cancer 5Health News:Montessori Schools kids do better in Reading and Math 2Health News:Laws That Make Parental Consent Mandatory Reduce Risky Sexual Behavior 2Health News:Nepal Plans to Promote Health Tourism Based on Traditional Medicine 2
... higher magnification for advanced surgical procedures. Prismatic ... at the highest magnification. 3.5x, 4.5x and ... color rendition is ideal for surgical applications. ... produce a superior image. The compact abd ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
... Made up of doublet objective and high ... 2.5x and 3.0x. The true benefit of ... whilst maintaining focal clarity is made possible ... The ultra lightweight aluminum bar and individual ...
... Galilean loupes are ideal for general ... magnification and a large field of ... laser aligned, lightweight and comfortable to ... distance and superior depth of focus ...
Medicine Products: